Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 14

Page
per page
  1. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: inhibitor of Ubiquitin-Activating Enzyme (E1)
  2. VR23
    B6026 VR23
    Target: Proteasome
    Summary: proteasome inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
  3. MG-262
    A8179 MG-262
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  4. MLN9708
    A4007 MLN9708
     3 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      insoluble in H2O; ≥20.85 mg/mL
  5. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  6. Clasto-Lactacystin β-lactone
    A2578 Clasto-Lactacystin β-lactone
    Target: Proteasome
    Summary: Proteasome inhibitor
      Soluble in DMSO
  7. Lactacystin (Synthetic)
    A2583 Lactacystin (Synthetic)
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      Soluble in H2O
  8. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  9. ONX-0914 (PR-957)
    A4011 ONX-0914 (PR-957)
     6 Citation
    Target: Proteasome
    Summary: Immunoproteasome inhibitor,potent and selective
      ≥29.03 mg/mL
  10. Salinosporamide A (NPI-0052, Marizomib)
    A4010 Salinosporamide A (NPI-0052, Marizomib)
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      Soluble in DMSO

Items 1-10 of 14

Page
per page